Leptin receptor polymorphism increases the risk of painful symptoms in Brazilian women with endometriosis

article OA: gold CC0
AI-generated summary by claude@2026-06, 2026-06-07

The rs1137100 polymorphism in the leptin receptor gene was associated with increased risk of chronic pelvic pain and dyspareunia in Brazilian women with endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07

This retrospective study in two Brazilian public hospitals evaluated whether leptin (LEP) and leptin receptor (LEPR) polymorphisms (LEP rs7799039 and LEPR rs1137100) are associated with painful symptoms in 237 women with endometriosis, grouping participants by absence versus presence of severe and disabling symptoms. Most cases reported painful symptoms, including dysmenorrhea (82%), dyspareunia (67%), and chronic pelvic pain (53%), and genetic analysis was performed by real-time PCR with odds ratio estimation via non-conditional logistic regression. The LEPR rs1137100 polymorphism showed significant associations with chronic pelvic pain (OR=1.75; 95% CI 1.05–2.89) and dyspareunia (OR=1.78; 95% CI 1.01–3.12), while the abstract does not report similarly significant results for LEP rs7799039. This paper is centrally about endometriosis — it links a specific LEPR genetic polymorphism (rs1137100) to increased endometriosis-related painful symptoms.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

OBJECTIVE: Endometriosis pain is associated with inflammatory cytokines, such as leptin (LEP), through activation with its receptor (LEPR), and its expression can be influenced by the presence of genetic polymorphisms. Therefore, this study aims to evaluate the role of the LEP rs7799039 and LEPR rs1137100 polymorphisms in the painful symptoms of endometriosis in Brazilian women. METHODS: A retrospective study was carried out in two Brazilian public hospitals with 237 cases of endometriosis, divided into two comparison groups according to the painful symptoms associated with the disease (absence or presence of severe and disabling symptoms). Genetic analysis was performed by real-time PCR technique, and association analyses were estimated using odds ratio (OR) and 95% confidence interval (CI), using a non-conditional logistic regression model. RESULTS: Endometriosis cases showed a high prevalence of painful symptoms: 82% dysmenorrhea, 67% dyspareunia, 53% chronic pelvic pain, and 52% cyclical intestinal and 25% urinary complaints. Regarding genetic analyses, cases had 32.7% of the A allele and 11.4% of the AA genotype for the LEP rs7799039 G>A SNP, and 17.5% of the G allele and 2.5% for of GG genotype for the LEPR rs1137100 A>G SNP. There is a significant association of the LEPR rs1137100 polymorphism with chronic pelvic pain (OR=1.75; CI 95%=1.05-2.89) and dyspareunia (OR=1.78; CI 95%=1.01-3.12) in women with endometriosis. CONCLUSION: Our findings suggest that the LEPR rs1137100 polymorphism is associated with increased endometriosis-related gynecological pain and may be a potential target for molecular diagnosis of the disease and development of individualized treatment strategies.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_paindyspareunia

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (27)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pmc
last seen: 2026-05-13T20:22:03.195721+00:00
pubmed
last seen: 2026-06-11T06:16:12.914779+00:00
License: CC0 · commercial use OK